GP6 and neoplasm: Furthermore, they allow us to validate GPVI as an ideal target, thanks to its minimal effect on bleeding and its contribution to late steps of tumor metastasis, which makes it an appealing candidate for testing its anti-metastatic potential in a human-relevant context.